Alexion Not Scared Of Amgen Biosimilar Threat To Soliris

Companies Settled Eculizumab Litigation In US Earlier This Year

Balancing time and money
Alexion is not fazed by the potential for biosimilar competition to Soliris • Source: Shutterstock

More from Biosimilars

More from Products